Health Condition 1: O00-O9A- Pregnancy, childbirth and the puerperium
Conditions
Interventions
Intervention1: ONDANSTERON: Single time Inj Ondansetron 4 mg diluted in 9 ml of normal saline
Control Intervention1: GRANISETRON: Single time Inj Granisetron 1 mg diluted in 9 ml of normal saline
Sponsors
Dr Anurita K
Eligibility
Inclusion criteria
Inclusion criteria: 1.Parturients belonging to ASA II 2.Height of the patient 150-160cms 3.Parturients who are willing to give consent. 4.Parturients of normal singleton pregnancy beyond 36 weeks gestation posted for elective caesarean section.
Exclusion criteria
Exclusion criteria: 1.Parturients with hypersensitivity to study drug. 2.Parturients with significant coagulopathies and other contra-indications for spinal anaesthesia. 3.Parturients with pregnancy induced hypertension 4. Parturients with history of significant systemic disorders (cardiovascular, respiratory or central nervous system). 5.Parturients with fetal anomalies and twin gestation. 6.Parturients with oligohydramnios and polyhydramnois.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Effects of Ondansetron and Granisetron on SAB induced haemodynamics in parturients undergoing elective LSCSTimepoint: 0 Minute, 2 Minute, 4 Minute, 6 minute, 8 minute, 10 minute, 15 minute, 20 minute, 25 minute, 30 minute, 40 minute, 50 minute, 60 minute | — |
Secondary
| Measure | Time frame |
|---|---|
| Over all Safety of the drugsTimepoint: 0 Minute, 2 Minute, 4 Minute, 6 minute, 8 minute, 10 minute, 15 minute, 20 minute, 25 minute, 30 minute, 40 minute, 50 minute, 60 minute | — |
Countries
India
Contacts
Public ContactDr Yoganarasimha N
BGS Global Institute of Medical Sciences
Outcome results
None listed